Crossmark

Comparison between calcium channel blocker with angiotensin converting enzyme inhibitor or angiotensin II type 1 receptor blocker combination on the development of new-onset diabetes in hypertensive Korean patients

Crossref DOI link: https://doi.org/10.1007/s40200-020-00521-4

Published Online: 2020-04-03

Published Print: 2020-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Yong Hoon

Her, Ae-Young

Rha, Seung-Woon

Choi, Byoung Geol

Choi, Se Yeon

Byun, Jae Kyeong

Kang, Dong Oh

Jang, Won Young

Kim, Woohyeun

Baek, Ju Yeol

Choi, Woong Gil

Kang, Tae Soo

Ahn, Jihun

Park, Sang-Ho

Park, Sung Hun

Hong, Ji Yeon

Park, Ji Young

Lee, Min-Ho

Choi, Cheol Ung

Park, Chang Gyu

Seo, Hong Seog
License Information

Text and Data Mining valid from 2020-04-03

Version of Record valid from 2020-04-03
More Information

Article History

Received: 27 November 2019

Accepted: 20 March 2020

First Online: 3 April 2020

Compliance with ethical standards

:

: The authors state that there is no conflict of interests in the present research study.

Document is current

Any future updates will be listed below